Healthcare -
Biotechnology - NASDAQ - US
$ 9.5
0.849 %
$ 968 M
Market Cap
-1.74
P/E
NTLA - ACCOUNTS PAYABLE
Accounts Payable NTLA - Intellia Therapeutics, Inc.
7.45 M
LAST VALUE
-12.14%
2 YEAR CAGR
22.44%
5 YEAR CAGR
0.00%
10 YEAR CAGR